Terivac
Terivac
Authorised
- Turkey rhinotracheitis virus, strain VCO3, Live
Product identification
Medicine name:
Terivac
Active substance:
- Turkey rhinotracheitis virus, strain VCO3, Live
Target species:
-
Turkey
Route of administration:
-
Nebulisation use
-
In drinking water/milk use
-
In drinking water use
Product details
Active substance and strength:
-
Turkey rhinotracheitis virus, strain VCO3, Live199.53/tissue culture infective dose 501.00Dose
Pharmaceutical form:
-
Lyophilisate for oral suspension
Withdrawal period by route of administration:
-
Nebulisation use
- Turkey
-
Meat and offal0day
-
-
In drinking water/milk use
- Turkey
-
Meat and offal0day
-
-
In drinking water use
- Turkey
-
Meat and offal0day
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI01CD01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Germany
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
- Boehringer Ingelheim Vetmedica GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
- Boehringer Ingelheim Animal Health France
Responsible authority:
- Paul-Ehrlich-Institut
Authorisation number:
- 106a/90
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 9/03/2022
How useful was this page?:
